DaShenLin Pharmaceutical Group Co., Ltd.SSE: 603233

(603233)"DaShenLin Pharmaceutical Group Co., Ltd."Announcement on Key Operating Data for Q3 2026

Oct 30, 2026 · Issued by DaShenLin Pharmaceutical Group Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 603233 · Oct 30, 2026 · 4 pages · Chinese

On 6ix: 6ix.com/news/603233dashenlin-pharmaceutical-group-co-ltdannouncement-on-key-operating-data-for-q3-2026

DaShenLin Pharmaceutical Group Co., Ltd. on 6ix

Story so far

(603233)"DaShenLin Pharmaceutical Group Co., Ltd."Announcement on Results of Redemption at Maturity of "DaShenLin Convertible Bonds" and Share ChangesOct 23, 2026
(603233)"DaShenLin Pharmaceutical Group Co., Ltd."Announcement on Redemption at Maturity and Delisting of "DaShenLin Convertible Bonds"Oct 14, 2026
(603233)"DaShenLin Pharmaceutical Group Co., Ltd."Announcement on Implementation of Dividend Distribution for the First Half of 2026Oct 12, 2026

Earlier from DaShenLin Pharmaceutical

Later from DaShenLin Pharmaceutical

(603233)"DaShenLin Pharmaceutical Group Co., Ltd."Announcement on Release of Pledge of Shares Held by the Controlling ShareholderNov 4

All DaShenLin Pharmaceutical news releases

Follow DaShenLin Pharmaceutical into a list and get an email when it puts out news.

Follow DaShenLin Pharmaceutical